炎症性肠病通过自身免疫中介增加听力损失风险的孟德尔随机化研究
本研究采用两样本孟德尔随机化方法,利用欧洲IEU数据库的炎症性肠病GWAS汇总数据(样本量75 000)和芬兰数据库的听力损失GWAS汇总数据(样本量196 592),评估炎症性肠病与听力损失的因果关系及自身免疫的中介作用。逆方差加权分析显示炎症性肠病是听力损失的危险因素(OR:1.055,95%CI:1.006~1.105,P=0.026),中介分析中间接效应显著(95%CI:<0.001~0.015,P=0.048),直接效应不显著。结论认为炎症性肠病可通过自身免疫介导机制增加听力损失风险。
要点
- 炎症性肠病是听力损失的危险因素(OR:1.055,95%CI:1.006~1.105,P=0.026)。
- 自身免疫是听力损失的危险因素(OR:2.822,95%CI:1.115~7.142,P=0.029)。
- 中介分析示间接效应显著(95%CI:<0.001~0.015,P=0.048),直接效应不显著。
核心结论
- 炎症性肠病可通过自身免疫介导机制增加听力损失的风险。
研究设计与样本
- 两样本孟德尔随机化研究,炎症性肠病GWAS汇总数据来自欧洲IEU数据库(样本量75 000),听力损失GWAS汇总数据来自芬兰数据库(样本量196 592)。
- 采用逆方差加权法、MR-Egger回归法、加权中位数法、简单模式法和加权模式法进行因果推断。
- 采用Cochran's Q异质性检验、MR_pleiotropy_test函数、MR PRESSO多效性检验、MR_leaveoneout_plot敏感性分析,并计算F值评估弱工具变量偏倚。
主要发现
- 逆方差加权分析显示炎症性肠病是听力损失的危险因素(OR:1.055,95%CI:1.006~1.105,P=0.026)。
- 炎症性肠病与自身免疫存在因果关系(OR:1.008,95%CI:1.005~1.010,P<0.001)。
- 自身免疫是听力损失的危险因素(OR:2.822,95%CI:1.115~7.142,P=0.029)。
- 中介分析中直接效应不显著(95%CI:-0.002~0.092,P=0.062),间接效应显著(95%CI:<0.001~0.015,P=0.048)。
临床怎么用
- 对炎症性肠病患者应关注听力损失的筛查与监测,考虑自身免疫介导机制的可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: This study investigates the intriguing causal relationship between inflammatory bowel disease (IBD) and the risk of hearing loss (HL). Furthermore, an attempt was made to quantify the role of immunization as a potential mediator. Methods: Our research process was meticulously designed and executed. We pooled data from gene-wide association studies (GWAS) obtained IBD data from the European IEU database (website: https://gwas.mrcieu.ac.uk/) and GWAS data for HL from the Finnish database (website: https://www.finngen.fi/fi). We then applied a range of rigorous statistical methods, including the inverse-variance weighted (IVW) method, Mendelian randomization (MR)-Egger regression method, weighted median (WME), simple mode (SM), and weighted mode (WM), to perform two-sample MR analysis and to evaluate a causal relationship of IBD on HL risk in terms of odds ratio (OR) and 95% confidence interval (CI). We also conducted Cochran's Q heterogeneity test by IVW and MR-Egger regression, respectively, and multiple validity test by MR_pleiotropy_test function, MR PRESSO, and sensitivity analysis by MR_leaveoneout_plot function, and F-values were computed to assess the presence of weak instrumental variable bias. Results: The IVW analysis indicated that IBD was a risk factor for HL (OR: 1.055, 95%CI: 1.006-1.105, P=0.026). Furthermore, the analysis demonstrated a causal relationship between IBD and autoimmunity (OR: 1.008, 95%CI: 1.005-1.010, P<0.001). In addition, autoimmunity was found to be a risk factor for HL (OR: 2.822, 95%CI: 1.115-7.142, P=0.029). In the mediation analysis, the direct effect was not significant (95%CI:-0.002-0.092, P=0.062), while, the indirect effect was significant (95%CI:<0.001-0.015, P=0.048). Conclusions: IBD has been demonstrated to heighten the probability of developing HL through the action of autoimmunity-mediated mechanisms. 目的: 探讨炎症性肠病(inflammatory bowel disease)与听力损失(hearing loss)风险之间的因果关系,并量化自身免疫作为潜在中介的作用。 方法: 对全基因组关联分析(genome-wide association study,GWAS)的汇总数据进行分析,炎症性肠病的GWAS汇总数据来源于欧洲IEU数据库(网站:https://gwas.mrcieu.ac.uk/),样本量75 000;听力损失的GWAS汇总数据来源于芬兰数据库(网站:https://www.finngen.fi/fi),样本量为196 592。应用逆方差加权(inverse-variance weighted method,IVW)法、MR-Egger回归法、加权中位数(weighted median,WME)法、简单模式(simple mode,SM)法和加权模式(weighted mode,WM)法行两样本孟德尔随机化分析,以比值比(OR值)和95%置信区间(CI)评价炎症性肠病对听力损失风险的因果关系。分别采用IVW法和MR-Egger法进行Cochran′s Q异质性检验,用MR_pleiotropy_test函数、MR PRESSO进行多效性检验,MR_leaveoneout_plot函数进行敏感性分析,并计算F值以评估是否存在弱工具变量偏倚。 结果: IVW结果显示炎症性肠病是听力损失的危险因素(OR:1.055,95%CI:1.006~1.105,P=0.026);炎症性肠病与自身免疫存在因果关系(OR:1.008,95%CI:1.005~1.010,P<0.001V);自身免疫是听力损失的危险因素(OR:2.822,95%CI:1.115~7.142,P=0.029)。在中介分析中,直接效应并不显著(95%CI:-0.002~0.092,P=0.062),间接效应显著(95%CI:<0.001~0.015,P=0.048)。 结论: 炎症性肠病可以通过自身免疫介导增加听力损失的风险。.
引用
- Xia XY, Huang JZ, Pu KL, et al. [Inflammatory bowel disease increases the risk of hearing loss via autoimmunity: a Mendelian randomization study]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2026. PMID: 41956766. doi:10.3760/cma.j.cn115330-20250425-00253
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。